Komori
Changes in Officers4596Kubota Pharmaceutical Holdings Co.,Ltd.Pharmaceuticals

Notice Regarding Changes in Officers

A proposal to appoint Kubota Ryo (窪田 良) as a director serving concurrently as Representative Director, Chairman, President and Chief Executive Officer will be submitted to the annual general meeting of shareholders scheduled for 24 April 2026. The 3 outside directors serving as Audit and Supervisory Committee members will continue in office under the current structure, as their terms have not expired.

Worth reading
33Immaterial
0–100. This measures how worthwhile something is to read, not how good or bad the company is.
Direction
Neutral
Direction inferred from the company’s description.
Scale
—
Displayed only when the document provides numerical figures.
Wording
Conditional
How definitive the wording is.

Who is moving to which position

Resolved 18 March 2026

Incoming appointee

1 item
Scheduled Appointment DateConditional on appointment at the 11th annual general meeting of shareholders scheduled for 24 April 2026
Kubota Ryo (窪田 良)
Previous positionSame as above
New positionRepresentative Director, Chairman, President and Chief Executive Officer
Directors after the change4Number
Shareholders’ meeting approvalRequired. Proposal: Election of director candidates; scheduled meeting date: 24 April 2026
Who is moving to which position
ItemDetails
Resolution date18 March 2026
Scheduled Appointment DateConditional on appointment at the 11th annual general meeting of shareholders scheduled for 24 April 2026
Name of appointeeKubota Ryo (窪田 良)
Appointee's new positionRepresentative Director, Chairman, President and Chief Executive Officer
Appointee's previous positionSame as above
Number of directors after the change4 (including 3 outside directors)
Subject to Approval by the General Meeting of ShareholdersRequired. Proposal: Election of director candidates; scheduled meeting date: 24 April 2026
Items this document does not state (14)
Date of departureAppointee's date of birthYear the appointee joined the CompanyNumber of shares held by the appointeeName of departing officerFormer position of departing officerNew position of departing officerReason for departureWhether the incumbent will remain in officeReason for changeReasons for appointmentFiling as an independent officerDetails of organizational changesChange in Corporate Governance Structure

These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.

The reasons the company gives

The company's own explanation, not something inferred from the numbers.

The reason for the personnel change is not stated.

How to read this page

This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.
Notice Regarding Changes in Officers | Kubota Pharmaceutical Holdings Co.,Ltd. (4596) timely disclosure | Komori